Sprint Bioscience AB | |
Stock Exchange | First North Sweden |
EPS |
SEK1.75 |
Market Cap |
SEK189.88 M |
Shares Outstanding |
10.1 M |
Public Float |
- |
Address |
Hälsovägen 7 Huddinge AB 141 57 Sweden |
Employees | - |
Website | http://www.sprintbioscience.com |
Updated | 09/14/2018 |
Sprint Bioscience AB engages in the business of drug development. It develops medicines in the field of cancer and metabolism. The company serves as preclinical part of the development process. |